About Us

JDT Completed the Translation of the Therapeutic Drug Data of COVID-19

2022-11-17

In September 2022, according to the new drug application requirements of regulatory agencies, with the joint effort of the translation team and the post-typesetting team, the therapeutic drug data of COVID-19 was completed on time with high quality and submitted in accordance with the project timeline, which received praise from the client.

上一篇:JDT Completed the Translation of the Information on a Gene Therapy Product 下一篇:Statement on Registered Capital Increase of JDT

Recommended news